Reaction
Eczema Herpeticum reporting signals
As of the last recalculation, Eczema Herpeticum appears in 449 FAERS reports alongside 7 co-occurring drug terms. The strongest observed disproportionality signal is BARICITINIB (PRR 64.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Baricitinib | 13 | 64.3 | 64.4 |
| Upadacitinib | 83 | 57.7 | 57.7 |
| Fexofenadine Hcl | 8 | 40.8 | 40.9 |
| Mometasone | 15 | 39.2 | 39.2 |
| Tofacitinib Citrate | 7 | 25.1 | 25.1 |
| Nemolizumab-Ilto | 4 | 14.7 | 14.7 |
| Dupilumab | 79 | 9.0 | 9.0 |